SCHEMBL8295232

SCHEMBL8295232

Cc1cnc2c(NCCN(C)C)nc3cc4ccccc4cc3n12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 18/20 0.76
CHUK O15111 15/20 0.76
CDK11B P21127 2/20 0.55
CDK7 P50613 2/20 0.55
CDK13 Q14004 2/20 0.55
MAP3K19 Q56UN5 2/20 0.55
MYLK4 Q86YV6 2/20 0.55
CDK11A Q9UQ88 2/20 0.55
ERN1 O75460 1/20 0.55
RPS6KA4 O75676 1/20 0.55
PRKD3 O94806 1/20 0.55
CDK1 P06493 1/20 0.55
KIT P10721 1/20 0.55
CDK2 P24941 1/20 0.55
TYK2 P29597 1/20 0.55
CSNK1D P48730 1/20 0.55
CDK9 P50750 1/20 0.55
LIMK1 P53667 1/20 0.55
CDK16 Q00536 1/20 0.55
MAPK7 Q13164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5137193 0.86 IKBKB (1.00) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL4984117 0.86 IKBKB (1.00) IKBKBCHUKCDK11BCDK7CDK13
Hydrochloric Acid SCHEMBL5749193 0.85 IKBKB (1.00) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL5076827 0.81 IKBKB (1.00) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL5748334 0.80 IKBKB (1.00) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL14431795 0.77 IKBKB (1.00) IKBKBCHUK
SCHEMBL8112284 0.72 IKBKB (0.76) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL4980052 0.72 IKBKB (0.67) IKBKBCHUKCDK11BCDK7CDK13
SCHEMBL25735941 0.71 IKBKB (0.80) IKBKBCHUKCDK11BCDK7CDK13
Bms-345541 SCHEMBL118886 0.71 IKBKB (1.00) IKBKBCHUKCDK11BCDK7CDK13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005009354-A2 COMPOSITIONS OF A CYCLOOXYGENASE-2 SELECTIVE INHIBITOR AND AN IKK INHIBITOR FOR THE TREATMENT OF ISCHEMIC-MEDIATED CENTRAL NERVOUS SYSTEM DISORDERS OR INJURY PHARMACIA CORPORATION (US) 2005-02-03 WO disclosed